Columbus, OHNCT07465289Now EnrollingIRB Ready

Ocular Myasthenia Gravis Clinical Trial in Columbus, OH

Access cutting-edge ocular myasthenia gravis treatment through this phase 3 clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.

Sponsored by UCB Biopharma SRL

Quick Self-Assessment

See if you qualify for this Columbus location

Preparing your pre-screening questions…

Expert Care in Columbus

Access ocular myasthenia gravis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ocular myasthenia gravis treatment provided free

Apply for This Columbus Location

Check if you qualify for this ocular myasthenia gravis clinical trial in Columbus, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Columbus

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Columbus site if eligible
  4. 4Begin participation

About This Ocular Myasthenia Gravis Study in Columbus

The purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.

Sponsor: UCB Biopharma SRL

Who Can Participate

Inclusion Criteria

Participant must be a minimum of 18 years of age inclusive at the time of signing the informed consent form (ICF)
Participant must have received at least 1 dose of investigational medicinal product (IMP) (rozanolixizumab or placebo) in MG0038
Participant for whom the investigator considers a favorable benefit/risk for participation
Participant who, alone or with assistance of the caregiver, is considered reliable and capable of adhering to the protocol visit schedule or medication intake according to the judgement of the investigator
Male or female
A female participant is eligible to participate if she is not, not breastfeeding (including pumping breastmilk to feed a child), and at least 1 of the following conditions applies:
Not a woman of childbearing potential (WOCBP) OR
A WOCBP who agrees to follow the contraceptive guidance for the entire study period
Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the ICF and in the protocol

Exclusion Criteria

Participant meets any of the withdrawal criteria defined in MG0038
Participant has a clinically relevant active infection (resulting in hospitalization or requiring intravenous (IV) antibiotic treatment) within 6 weeks before study entry.
Participant intends to have a live vaccination during the study or within 8 weeks following the final dose of rozanolixizumab
Participant has been administered with the prohibited immunosuppressive medications, biologics, or other therapies
Participant has planned use of prohibited medications

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Columbus?

Yes, this clinical trial (NCT07465289) has an active research site in Columbus, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ocular Myasthenia Gravis Treatment Options in Columbus, OH

If you're searching for ocular myasthenia gravis treatment options in Columbus, OH, this clinical trial (NCT07465289) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Columbus research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced ocular myasthenia gravis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ocular myasthenia gravis clinical trials near you to find additional studies recruiting in your area.

More Myasthenia Gravis Trials in Columbus, OH

See all myasthenia gravis clinical trials recruiting in Columbus — not just this study.

Browse Myasthenia Gravis Trials in Columbus →

Browse More Trials by Condition

Myasthenia Gravis TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Columbus?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Columbus, OH